Is breast conservation therapy a viable option for patients with triple-receptor negative breast cancer?

Surgery

Volumn 148, Issue 2, 2010, Pages 386-391

  Parker, Catherine C ^a   Ampil, Fred ^a   Burton, Gary ^a   Li, Benjamin D L ^a,b   Chu, Quyen D ^a,b  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CONSERVATION THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MASTECTOMY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TRIPLE RECEPTOR NEGATIVE BREAST CANCER; BREAST TUMOR; FEMALE; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; SEGMENTAL MASTECTOMY; TUMOR RECURRENCE;

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TREATMENT OUTCOME;

EID: 77955285817     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2010.05.018     Document Type: Article

References (15)

1. C.M. Perou, T. Sørlie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, and C.A. Rees Molecular portraits of human breast tumours Nature 406 2000 747 752
2. C. Sotiriou, S.Y. Neo, L.M. McShane, E.L. Korn, P.M. Long, and A. Jazaeri Breast cancer classification and prognosis based on gene expression profiles from a population based study Proc Natl Acad Sci USA 100 2003 10393 10398
3. T. Sørlie, C.M. Perou, R. Tibshirani, T. Aas, S. Geisler, and H. Johnsen Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 2001 10869 10874
4. L.J. van 't Veer, H. Dai, M.J. van de Vijver, Y.D. He, and A.A. Hart Gene expression profiling predicts clinical outcome of breast cancer Nature 415 2002 530 536
5. F.L. Greene, D.L. Page, I.D. Fleming, AJCC Cancer Staging Manual 6th ed. 2002 Springer New York
6. L.A. Carey, C.M. Perou, C.A. Livasy, L.G. Dressler, D. Cowan, and K. Conway Race, breast cancer subtypes and survival in the Carolina Breast Cancer Study JAMA 295 2006 2492 2502
7. E.H. Romond, E.A. Perez, J. Bryant, V.J. Suman, C.E. Geyer Jr., and N.E. Davidson Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer N Engl J Med 353 2005 1673 1684
8. E.A. Rakha, M.E. El-Sayed, A.R. Green, A.H. Lee, J.F. Robertson, and I.O. Ellis Prognostic markers in triple-negative breast cancer Cancer 109 2007 25 32
9. I. Matos, R. Dufloth, M. Alvarenga, L.C. Zeferino, and F. Schmitt p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas Virchows Arch 447 2005 688 694
10. B.G. Haffty, Q. Yang, M. Reiss, T. Kearney, S.A. Higgins, and J. Weidhaas Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer J Clin Oncol 24 2006 5652 5657
11. G.M. Freedman, P.R. Anderson, T. Li, and N. Nicolaou Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation Cancer 115 2009 946 951
12. P.L. Nguyen, A.G. Taghian, M.S. Katz, A. Niemierko, R.F. Abi Raad, and W.L. Boon Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy J Clin Oncol 26 2008 2373 2378
13. L.J. Solin, W.T. Hwang, and N. Vapiwala Outcome after breast conservation treatment with radiation for women with triple-negative early-stage invasive breast carcinoma Clin Breast Cancer 9 2009 96 100
14. B. Fisher, S. Anderson, J. Bryant, R.G. Margolese, M. Deutsch, and E.R. Fisher Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer N Engl J Med 347 2002 1233 1241
15. M. Kyndi, F.B. Sørensen, H. Knudsen, M. Overgaard, H.M. Nielsen, and J. Overgaard Danish Breast Cancer Cooperative Group. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group J Clin Oncol 26 2008 1419 1426